Federated Hermes’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.25M Sell
617,318
-296,131
-32% -$1.08M ﹤0.01% 912
2025
Q1
$1.75M Sell
913,449
-554
-0.1% -$1.06K ﹤0.01% 968
2024
Q4
$1.74M Buy
914,003
+45,982
+5% +$87.4K ﹤0.01% 966
2024
Q3
$1.15M Buy
868,021
+2,769
+0.3% +$3.66K ﹤0.01% 1075
2024
Q2
$883K Sell
865,252
-1,302
-0.2% -$1.33K ﹤0.01% 1150
2024
Q1
$1.59M Hold
866,554
﹤0.01% 999
2023
Q4
$1.07M Sell
866,554
-98,639
-10% -$122K ﹤0.01% 1112
2023
Q3
$1.1M Hold
965,193
﹤0.01% 1083
2023
Q2
$883K Sell
965,193
-54,839
-5% -$50.2K ﹤0.01% 1179
2023
Q1
$571K Hold
1,020,032
﹤0.01% 1366
2022
Q4
$589K Sell
1,020,032
-780,504
-43% -$450K ﹤0.01% 1316
2022
Q3
$569K Sell
1,800,536
-188,931
-9% -$59.7K ﹤0.01% 1304
2022
Q2
$702K Sell
1,989,467
-40,548
-2% -$14.3K ﹤0.01% 1268
2022
Q1
$1.46M Sell
2,030,015
-4,332
-0.2% -$3.11K ﹤0.01% 1116
2021
Q4
$4.6M Buy
2,034,347
+5,244
+0.3% +$11.9K 0.01% 834
2021
Q3
$5.84M Buy
2,029,103
+145,327
+8% +$419K 0.01% 789
2021
Q2
$7.14M Buy
1,883,776
+1,882,252
+123,507% +$7.13M 0.01% 747
2021
Q1
$5K Hold
1,524
﹤0.01% 2056
2020
Q4
$4K Sell
1,524
-309,797
-100% -$813K ﹤0.01% 2064
2020
Q3
$781K Buy
311,321
+38,362
+14% +$96.2K ﹤0.01% 1341
2020
Q2
$3.71M Buy
+272,959
New +$3.71M 0.01% 794
2019
Q4
Sell
-6,789
Closed -$27K 2204
2019
Q3
$27K Buy
6,789
+519
+8% +$2.06K ﹤0.01% 1793
2019
Q2
$30K Sell
6,270
-1,234
-16% -$5.9K ﹤0.01% 1744
2019
Q1
$61K Sell
7,504
-682
-8% -$5.54K ﹤0.01% 1635
2018
Q4
$45K Sell
8,186
-1,868
-19% -$10.3K ﹤0.01% 1669
2018
Q3
$89K Buy
10,054
+9,731
+3,013% +$86.1K ﹤0.01% 1680
2018
Q2
$3K Buy
323
+42
+15% +$390 ﹤0.01% 2060
2018
Q1
$3K Buy
281
+15
+6% +$160 ﹤0.01% 2016
2017
Q4
$4K Sell
266
-251
-49% -$3.77K ﹤0.01% 2006
2017
Q3
$10K Buy
517
+273
+112% +$5.28K ﹤0.01% 1836
2017
Q2
$4K Buy
+244
New +$4K ﹤0.01% 1970